Altium Capital Management LP Alnylam Pharmaceuticals, Inc. Transaction History
Altium Capital Management LP
- $29.1 Million
- Q1 2025
A detailed history of Altium Capital Management LP transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Altium Capital Management LP holds 25,000 shares of ALNY stock, worth $7.3 Million. This represents 23.21% of its overall portfolio holdings.
Number of Shares
25,000Holding current value
$7.3 Million% of portfolio
23.21%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ALNY
# of Institutions
720Shares Held
111MCall Options Held
978KPut Options Held
881K-
Capital World Investors Los Angeles, CA16.7MShares$4.89 Billion0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$3.81 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.79 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.15MShares$2.09 Billion0.44% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.42MShares$1.29 Billion0.79% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $35.9B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...